Regulation of cell proliferation and transdifferentiation compensates for ventilator-induced lung injury mediated by NLRP3 inflammasome activation

被引:2
|
作者
Liu, Huan [1 ]
Yang, Xuepeng [2 ]
Liu, Ge [3 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan, Peoples R China
[2] Jinan Second Peoples Hosp, Dept Ophthalmol, Jinan, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Ophtalmol, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
cell proliferation; NLRP3; inflammasome; transdifferentiation; VILI; REACTIVE ARTHRITIS; POLYARTHRITIS;
D O I
10.1002/iid3.1062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundMechanical ventilation is an important means of respiratory support and treatment for various diseases. However, its use can lead to serious complications, especially ventilator-induced lung injury (VILI). The mechanisms underlying this disease are complex, but activation of inflammatory signalling pathways results in activation of cytokines and inflammatory mediators, which play key roles in VILI. Recent studies have demonstrated that nod-like receptor protein 3 (NLRP3) inflammasome activation mediates VILI and also accompanied by cell proliferation and transdifferentiation to compensate for alveolar membrane damage. Type I alveolar epithelial cells (AECs I), which are involved in the formation of the blood-air barrier, are vulnerable to damage but cannot proliferate by themselves; thus, replacing AECs I relies on type II alveolar epithelial cells (AECs II).ObjectiveThe review aims to introduce the mechanisms of NLRP3 inflammasome activation and its inhibitors, as well as the mechanisms that regulate cell proliferation and transdifferentiation.MethodsA large number of relevant literature was searched, then the key content was summarized and figures were also made.ResultsThe mechanism of NLRP3 inflammasome activation has been further explored, including but not limited to pathogenic and aseptic inflammatory signals, such as, pathogenic molecular patterns and host-derived danger-associated molecular patterns activate toll-like receptor 4/nuclear factor-kappaB pathway or reactive oxygen species, cyclic stretch, adenosine triphosphate induce K+ efflux through P2X7, Ca2+ inflow, mitochondrial damage, etc, eventually induce NIMA-related kinase 7/NLRP3 binding and NLRP3 inflammasome activation. Not only that, the review also described in detail the inhibitors of NLRP3 inflammasome. And the mechanisms regulating cell proliferation and transdifferentiation are complex and unclear, including the Wnt/beta-catenin, Yap/Taz, BMP/Smad and Notch signalling pathways.ConclusionsNLRP3 inflammasome activation mediated VILI, and VILI is alleviated after interfering with its activation, and inflammation and repair exist simultaneously in VILI. Clarifying these mechanisms is expected to provide theoretical guidance for alleviating VILI by inhibiting the inflammatory response and accelerating alveolar epithelial cell regeneration in the early stage. Nod-like receptor protein 3 inflammasome activation induces ventilator-induced lung injury (VILI). But, the inflammatory process of VILI is accompanied by the proliferation and transdifferentiation of alveolar epithelial cells, the significance of this phenomenon is to inhibit the occurrence of VILI in the early stage by compensating for the inflammatory response via repairing damaged alveolar membranes.image
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
    Dadkhah, Mina
    Sharifi, Mohammadreza
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2025, 44 (02) : 98 - 111
  • [32] Dexmedetomidine Alleviates Hyperoxia-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation
    Zhang, Qiuyue
    Wu, Di
    Yang, Yang
    Liu, Tingting
    Liu, Hongyu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (05) : 1907 - 1919
  • [33] Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells
    Wang, Yanli
    Kong, Hui
    Zeng, Xiaoning
    Liu, Wenrui
    Wang, Zailiang
    Yan, Xiaopei
    Wang, Hong
    Xie, Weiping
    ONCOLOGY REPORTS, 2016, 35 (04) : 2053 - 2064
  • [34] ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
    Ren, Guangming
    Zhang, Xuanyi
    Xiao, Yang
    Zhang, Wen
    Wang, Yu
    Ma, Wenbing
    Wang, Xiaohan
    Song, Pan
    Lai, Lili
    Chen, Hui
    Zhan, Yiqun
    Zhang, Jianhong
    Yu, Miao
    Ge, Changhui
    Li, Changyan
    Yin, Ronghua
    Yang, Xiaoming
    EMBO JOURNAL, 2019, 38 (06)
  • [35] Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
    Chen, Jun
    Jia, Shaohui
    Xue, Xinxuan
    Guo, Chenggeng
    Dong, Kunwei
    FRONTIERS IN MICROBIOLOGY, 2025, 15
  • [36] RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice
    Jingxian Chen
    Shuang Wang
    Rong Fu
    Mianjing Zhou
    Tengyue Zhang
    Wenxu Pan
    Niansheng Yang
    Yuefang Huang
    Journal of Translational Medicine, 16
  • [37] RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice
    Chen, Jingxian
    Wang, Shuang
    Fu, Rong
    Zhou, Mianjing
    Zhang, Tengyue
    Pan, Wenxu
    Yang, Niansheng
    Huang, Yuefang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [38] Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance
    Dagenais, Maryse
    Saleh, Maya
    ONCOIMMUNOLOGY, 2016, 5 (05):
  • [39] Antioxidant mitoquinone ameliorates EtOH-LPS induced lung injury by inhibiting mitophagy and NLRP3 inflammasome activation
    Sang, Wenhua
    Chen, Sha
    Lin, Lidan
    Wang, Nan
    Kong, Xiaoxia
    Ye, Jinyan
    FRONTIERS IN IMMUNOLOGY, 2022, 13 : 973108
  • [40] HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation
    Shi, Xueyan
    Li, Tao
    Liu, Yanting
    Yin, Leijin
    Xiao, Lan
    Fu, Liyao
    Zhu, Yaxi
    Chen, Huan
    Wang, Kangkai
    Xiao, Xianzhong
    Zhang, Huali
    Tan, Sichuang
    Tan, Sipin
    FRONTIERS IN IMMUNOLOGY, 2022, 13